Navigation Links
Micell Technologies Presents Data on Novel Drug-Eluting Stents

Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3

Related medicine technology :

1. Neose Technologies to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
2. New Report Looking at Chiral Technologies Analyzes the Global Market Growth Forecasts Driven By Two Very Important Components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals
3. Palatin Technologies and King Pharmaceuticals Report Data Showing Improvements in Sexual Relationship and Self-Esteem in Patients with Erectile Dysfunction Treated with Bremelanotide
4. Palatin Technologies and King Pharmaceuticals Announce Plan To Present Results of Bremelanotide Phase 2b Studies in Men With Erectile Dysfunction
5. Genelabs Technologies Announces Presentation of Data on Non-Nucleoside HCV Polymerase Inhibitor at 20th International Conference on Antiviral Research Meeting
6. OncoGenex Technologies Announces Phase II Data of OGX-011 in Metastatic Breast Cancer at American Association for Cancer Research 2007 Annual Meeting
7. AVAX Technologies Presents Results of Phase I-II M-Vax Trial at Annual Meeting of American Association for Cancer Research
8. Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery of GLP-1 and PYY
9. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
10. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
11. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Micell Technologies Presents Data Novel Drug Eluting Stents
(Date:12/1/2009)...FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a b...tary antibodies for the treatment of cancer, infla...at Bayer Schering Pharma AG has exercised its opti...eement entered into on January 12, 2009 to develop...mors. ,, Under the terms of the agreement, Baye...
(Date:11/30/2009)...ewswire/ -- Microban International, Ltd., the glob...tion, is pleased to announce their exclusive North...est U.S. manufacturer and distributor of ceramic t... two new lines of ceramic tile with OutStand Techn...g silver based technology, in order to create a li...
(Date:11/30/2009)...Newswire-FirstCall/ -- Nektar Therapeutics (Nasdaq...e Masuoka, M.D. to Senior Vice President and Chief...y to Nektar,s President and Chief Executive Office...g leadership and highly effective clinical develop...advancing Nektar,s proprietary clinical pipeline, ...
Breaking Medicine Technology:Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 2Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 3Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 4Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology 2Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 2Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 3Midlife Heart Risk Factors Linked to Later Dementia 53613 1Midlife Heart Risk Factors Linked to Later Dementia 53613 2Midlife Heart Risk Factors Linked to Later Dementia 53613 3CVS Caremark and Inverness Medical Innovations Launch Strategic Alliance to Provide Enhanced Health Management Services to Clients 53611 1CVS Caremark and Inverness Medical Innovations Launch Strategic Alliance to Provide Enhanced Health Management Services to Clients 53611 2CVS Caremark and Inverness Medical Innovations Launch Strategic Alliance to Provide Enhanced Health Management Services to Clients 53611 3CVS Caremark and Inverness Medical Innovations Launch Strategic Alliance to Provide Enhanced Health Management Services to Clients 53611 4More Than One in Five 12 to 17 Year Olds Have Trouble Seeing in Class 53609 1More Than One in Five 12 to 17 Year Olds Have Trouble Seeing in Class 53609 2More Than One in Five 12 to 17 Year Olds Have Trouble Seeing in Class 53609 3More Than One in Five 12 to 17 Year Olds Have Trouble Seeing in Class 53609 4
...BRISBANE, Australia, May 8 Implicit Bioscience Lt...tion of a manufacturing contract to support the ne...C14, a clinical-stage monoclonal antibody for acut...ty profile in over 150 patient exposures, and init...ly-ventilated patients has provided a clear ration...
...Isolagen(TM), Inc. (NYSE Amex: ILE ) today annou...ration ("FDA") has completed its initial review of...") related to its Nasolabial Fold/Wrinkles product...) the BLA for full review. , , In a communication...ed that it had completed its initial review of the...
Other Medicine Technology:CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License 2CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License 3CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License 4Food and Drug Administration Accepts Isolagen's Biologics License Application for Full Review 2Food and Drug Administration Accepts Isolagen's Biologics License Application for Full Review 3
(Date:11/30/2009)...ty is attempting to dispel the notion that all U.S...tients home pregnant with multiples. While they w...priority is health and safety. In addition, they ...on a country’s healthcare system. , ...any patients and doctors in the U.K. worry that cr...
(Date:11/30/2009)...Results of a randomized, controlled clinical trial...ological Society of North America (RSNA) reveal th... in arteries that supply blood to the legs and oth...ent coronary artery disease. ,, Peripheral art...ion of fat, cholesterol and other substances, buil...
(Date:11/30/2009)...High-frequency ultrasound with elastography can he... conditions, according to a study presented today ...of North America (RSNA). ,, "High-frequency ult...rove the efficiency of skin cancer diagnosis," sai... of the Department of Radiology at the University ...
(Date:11/30/2009)...A study presented today at the annual meeting of t...vealed that MRI is a highly accurate means of iden...tening and increasingly common condition that is t...d after giving birth. ,, "Due to the increase ...e scarring on the uterine wall, coupled with women...
(Date:11/30/2009)...ire-FirstCall/ -- VitaminSpice (OTC Bulletin Board...Bill" R. Fields to the Board of Directors. ,, M...source Co. Ltd. Mr. Fields is a Director of Lexmar...d as Chairman and Chief Executive Officer of Facto...nd Chief Executive Officer of Hudson,s Bay Company...
Breaking Medicine News(10 mins):Health News:East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program 2Health News:East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program 3Health News:Severe Asymptomatic Heart Disease May Accompany Narrowing in Leg Arteries 2Health News:Severe Asymptomatic Heart Disease May Accompany Narrowing in Leg Arteries 3Health News:Special Ultrasound Accurately Identifies Skin Cancer 2Health News:Special Ultrasound Accurately Identifies Skin Cancer 3Health News:MRI Helps Detect Life-Threatening Pregnancy Complication 2Health News:MRI Helps Detect Life-Threatening Pregnancy Complication 3Health News:VitaminSpice Elects Bill Fields to the Board of Directors 2
...eportedly revealed that being a misfit in her grou...// The 30-year-old actress has further insist...lane, has saved her from the temptations of illega...ever taken coke, Femalefirst quoted her, as saying...
That snacking in-between meals plays a major role in causing obesity is well-known. It has now emerged that obese children are also more prone to fall a prey to dental decay. //
...dreas Meyer-Lindenberg, M.D., Ph.D., NIMH Genes Co...one oxytocin weeks the brain’s fear centre. When a...tutes of Health's (NIH) & National Institute of Me... response to the fear stimuli. Previous analy...
..., Stanford University as reported in the Journal H...d had regular check ups with their physicians show...had little trust on the treatment given by their d...at in African-Americans, the poor and the uninsure...
...g to a controversial guidance it has been proposed...ld have to forgo treatment on the NHS//. This c...other agencies. As the National Institute for Heal...e self-inflicted cause of the condition will influ...
...r drug which is approved for treatment to breast c...than 25% of women with breast cancer// produce thi...reast cancer very aggressive and resist chemothera...s but the drug is very costly and the Herceptin tr...
Other Medicine News:Health News:Oxytocin Boosts Trust and Reduces Fear. 2
...to provide the surgeon with surgical solutions for...linically successful P.F.C. Total Knee System intr...f innovation.,Indicated for procedures where mech...cruciate ligament, the cruciate substituting compo...
BioPro® Uni Knee, Total Resurfacing Preserves Bone Stock
Alpina® Total Knee System
OptiMumm™ Smoke Evacuator
Medicine Products: